MedPath

Browse drugs by first letter:

Drug Monographs

Drug Type
Biotech
Brand Names
Byooviz, Cimerli, Lucentis, Susvimo, Ranivisio, Rimmyrah, Ximluci, Epruvy (previously Ranibizumab Midas)
CAS Number
347396-82-1
Unique Ingredient Identifier
ZL1R02VT79
Summary
Ranibizumab is a recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular...

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.